Value of peri-operative chemotherapy in patients with CINSARC high-risk localized grade 1 or 2 soft tissue sarcoma: study protocol of the target selection phase III CHIC-STS trial
Abstract Background The value of chemotherapy in soft tissue sarcoma (STS) remains controversial. Several expert teams consider that chemotherapy provides a survival advantage and should be proposed in high-risk (HR) patients. However, the lack of accuracy in identifying HR patients with conventiona...
Main Authors: | Thomas Filleron, Sophie Le Guellec, Christine Chevreau, Bastien Cabarrou, Tom Lesluyes, Sabrina Lodin, Angélique Massoubre, Muriel Mounier, Muriel Poublanc, Frédéric Chibon, Thibaud Valentin |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2020-07-01
|
Series: | BMC Cancer |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1186/s12885-020-07207-3 |
Similar Items
-
CINSARC in high‐risk soft tissue sarcoma patients treated with neoadjuvant chemotherapy: Results from the ISG‐STS 1001 study
by: Anna Maria Frezza, et al.
Published: (2023-01-01) -
The CINSARC signature as a prognostic marker for clinical outcome in multiple neoplasms
by: Tom Lesluyes, et al.
Published: (2017-07-01) -
Immunologic constant of rejection signature is prognostic in soft-tissue sarcoma and refines the CINSARC signature
by: Jean-Yves Blay, et al.
Published: (2022-01-01) -
Study protocol of the TEC-ORL clinical trial: a randomized comparative phase II trial investigating the analgesic activity of capsaicin vs Laroxyl in head and neck Cancer survivors presenting with neuropathic pain sequelae
by: Antoine Boden, et al.
Published: (2022-12-01) -
Veggie chic /
by: 309540 Elliot, Rose
Published: (2006)